Drug Shortage Report for JAMP PIRFENIDONE
Report ID | 151702 |
Drug Identification Number | 02509938 |
Brand name | JAMP PIRFENIDONE |
Common or Proper name | Pirfenidone Capsules |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PIRFENIDONE |
Strength(s) | 267MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 63 (blister) |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-12-16 |
Actual start date | |
Estimated end date | 2025-12-31 |
Actual end date | 2024-04-26 |
Shortage status | Resolved |
Updated date | 2024-04-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-02-09 | English | Compare |
v2 | 2021-12-21 | French | Compare |
v1 | 2021-12-21 | English | Compare |